ISNTD D3 (diagnostics, drug discovery & development)

Event 19 Feb 2015
13

LSTM Professor Steve Ward and Dr Emily Adams are confirmed speakers on a two day conference which aims to address the shortfalls in R&D productivity and drive the development of future paths towards successful gains in the control, treatment or evaluation of NTDs.

ISNTD d3 will bring together experts from within drug discovery and clinical trials to drive the debate and foster new partnerships & alliances leading to tangible outcomes in terms of new therapies to combat these diseases.

ISNTD d3 also aims to accelerate the networking required for the development & distribution of new or improved drugs, vaccines, microbicides and diagnostics against the NTDs by bringing focus onto the phase II and III clinical trials taking place or set to take place potentially in affected countries.

For more information and registration information please visit: http://www.isntdd3.com/